Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Anticancer Research|April 27, 2024
Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker AnalysisToru Imai, Yuki Kojima, Tatsunori Shimoi, et al.
Breast Cancer Research and Treatment|November 17, 2022
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapyShu Yazaki, Tatsunori Shimoi, Masayuki Yoshida, et al.
Cancer Cell International|February 4, 2023
Changes in HER3 expression profiles between primary and recurrent gynecological cancersYuki Kojima, Kazuki Sudo, Hiroshi Yoshida, et al.
Frontiers in Oncology|April 13, 2023
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancerTomomi Sanomachi, Hitomi Sumiyoshi Okuma, Rui Kitadai, et al.
The New England Journal of Medicine|January 6, 2021
Vaginal Transmission of Cancer from Mothers with Cervical Cancer to InfantsAyumu Arakawa, Hitoshi Ichikawa, Takashi Kubo, et al.
Breast Cancer (Tokyo, Japan)|June 24, 2026
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trialTakashi Yamanaka, Joohyuk Sohn, Kazuki Sudo, et al.
NPJ Breast Cancer|August 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancerEmi Noguchi, Takashi Yamanaka, Hirofumi Mukai, et al.
Cancer|September 20, 2019
Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma NetworkAnna Maria Frezza, Tarek Assi, Salvatore Lo Vullo, et al.
Pageof 6